Dipentum
NDC 68151-0312
Product Information
Dipentum is a NDA-approved product labeled by Carilion Materials Management. Olsalazine is used to treat a certain type of bowel disease called ulcerative colitis. It is supplied as a white product. This product entry covers the primary NDC 68151-0312 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
DIPENTUM;250;MG
Code Structure Chart
Product Details
What is NDC 68151-0312?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- OLSALAZINE SODIUM (UNII: Y7JEW0XG7I)
- OLSALAZINE (UNII: ULS5I8J03O) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- CARAMEL (UNII: T9D99G2B1R)
- GELATIN, UNSPECIFIED (UNII: 2G86QN327L)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 905162 - olsalazine sodium 250 MG Oral Capsule
- RxCUI: 905164 - Dipentum 250 MG Oral Capsule
- RxCUI: 905164 - olsalazine sodium 250 MG Oral Capsule [Dipentum]
* Please review the full disclaimer at the bottom of this page.